Press Releases

ARLINGTON, VA / ACCESSWIRE / May 6, 2024 / Leading HR analytics software company HireRoad is proud to announce its new senior leadership team, a group of powerhouse leaders who bring expertise and industry respect to the growing team. They join CEO John Federman, who took the helm in September 2023. Collectively, the team will help further the brand's mission of providing critical people data and actionable insights to drive businesses forward.

HireRoad Chief Product... (continue reading...)

Recognized by independent research firm for its "strength in testing and optimization"

NEW YORK, May 6, 2024 /PRNewswire/ -- Optimizely, the leading digital experience platform (DXP) provider, today announced it has been named a Leader in The Forrester Wave™: Commerce Solutions for B2B, Q2 2024. In this evaluation, Optimizely was recognized for its strong testing and optimization capabilities, which the Forrester report notes "fewer than half of the vendors in this... (continue reading...)

PARIS--(BUSINESS WIRE)-- Regulatory News:

Clariane (Paris:CLARI) (CLARIA.PA - ISIN FR0010386334): the Group announces today that it has received a put option agreement from the Fondation Santé Service and has granted an exclusivity undertaking with a view to selling all its Hospitalisation à Domicile and Services de Soins Infirmiers à Domicile (HAD/SSIAD) activities in France. This agreement follows a bidding process involving several players in the... (continue reading...)

STOCKHOLM, May 6, 2024 /PRNewswire/ -- The Board of Directors of Loomis AB has resolved to repurchase shares by virtue of the authorization granted by the Annual General Meeting 2024.

The repurchase may commence on May 7, 2024, end not later than on June 24, 2024, and comprise an amount up to a maximum of SEK 200 million. Repurchase shall be made on Nasdaq Stockholm, on one or more occasions, at a price within the prevailing price interval registered at each point... (continue reading...)

SALT LAKE CITY--(BUSINESS WIRE)-- Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based technologies to target the African Swine Fever Virus (ASFV) in pigs. The trial, which aimed to replicate and expand an earlier trial, demonstrated pigs infected with ASFV and treated with... (continue reading...)